Comparison of efficacy of Trans cranial Electrical Stimulation (tDCS and tACS) with stimulant agents in adolescents with attention deficit hyperactive disorder (ADHD) and QEEG pattern

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201102049235N1

Enrollment

Registered

2021-11-14

Start date

2020-12-20

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-deficit hyperactivity disorders. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Subjects in the tDCS class undergo 5 sessions of 20 minutes every other day with 2 mA amplitude.stimulation will be performed with Neurostim device with electrodes in size of 5*5 CM

Eligibility

Sex/Gender

All

Age

12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Diagnosis of Attention Deficit Hyperactivity Disorder based on KSADs interviews

Exclusion criteria

Exclusion criteria: Neurological problems such as a history of epilepsy, seizures, strokes and tumors of the brain or spinal cord Pregnant or lactating patients

Design outcomes

Primary

Measure	Time frame
Score of hyperactivity and attention deficit. Timepoint: Before the start of the first session, after the last session and two weeks after the end of the sessions. Method of measurement: Connors Questionnaire.;QEEG pattern. Timepoint: Before the first session and two weeks after the end of the sessions. Method of measurement: with neuroguide program.;Parents satisfaction. Timepoint: before and after treatment. Method of measurement: conner's questionnaire.	—

Measure

Time frame

Score of hyperactivity and attention deficit. Timepoint: Before the start of the first session, after the last session and two weeks after the end of the sessions. Method of measurement: Connors Questionnaire.;QEEG pattern. Timepoint: Before the first session and two weeks after the end of the sessions. Method of measurement: with neuroguide program.;Parents satisfaction. Timepoint: before and after treatment. Method of measurement: conner's questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasibe sadati

Mazandaran University of Medical Sciences

nasibehsadati@gamil.com+98 11 3328 3886

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026